device adverse_event
saveESSURE — Injury event
March 31, 2026updated 5mo ago
community read0 votes
Break; Improper or Incorrect Procedure or Method
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- device adverse eventESSURE — Injury eventMar 31, 2026
- device adverse eventESSURE — Injury eventMar 31, 2026
- device adverse eventESSURE — Injury eventMar 31, 2026
- approvalNAPROXEN SODIUM: ALEVE (NAPROXEN SODIUM) — FDA approvalMar 10, 2026
- phase 1 initiationasundexian: Bayer AG — asundexian (Phase I Trial Initiation)Apr 29, 2026
- phase 1 2 completionavelumab: Bayer AG — avelumab (Phase I/II Trial Completion)Apr 30, 2026
comments(0)
5-min edit window · permanent after that